ISRCTN23940498已完成不适用
A prospective clinical trial of a multidisciplinary electronic cardiovascular prevention programme
De Onderlinge Ziekenkas (Belgium)0 个研究点目标入组 350 人开始时间: 2007年3月6日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age between 25-65
- •2. Insured by the Onderlinge Ziekenkas, insuring for guaranteed income in case of illness for self-employed
- •3. Inhabitants of Limburg
排除标准
- •People with a high cardiovascular risk are not excluded from the PreCardio-study, given the constant supervision GPs and a cardiologist involved in PreCardio. However, high risk participants are advised not to take part in certain rigourous training schemes available to the participants of the study
研究者
相似试验
尚未招募
Unknown
A prospective, randomized, multi-centered clinical trial to investigate the effectiveness of the digital therapeutic device 'StroKcare' for speech rehabilitation for people with post-stroke dysarthriaKCT0008505Korea Technology & Information Promotion Agency for SMEs68
Unknown
2 期
A clinical trial to evaluate efficacy and safety of R-TPR-004 in patients with acute ischemic strokeCTRI/2013/04/003590Reliance Life Sciences Pvt Ltd40
已完成
不适用
ifestyle intervention trial: a multidisciplinary lifestyle modification programmeRisk factors for stroke and cardiovascular diseaseCirculatory SystemComplications and ill-defined descriptions of heart diseaseISRCTN79355192meå University (Sweden)2,083
招募中
不适用
A prospective, multi-center, single-arm, clinical investigation of the safety and performance of the Sentio system in users with mixed/conductive hearing losses and single sided deafnesshearing impairmentNL-OMON51025Oticon Medical AB15
招募中
不适用
A prospective, single arm, multi-center, clinical evaluation of the Ablacath* Mapping Catheter and Ablamap® System utilizing Electrographic Flow (EGF) mapping to resolve extra-pulmonary vein sources Atrial Fibrillation sources and guide ablation therapy.irregular heartrhythm10007521atrial fibrillationNL-OMON56533Cortex Inc.60